Integer Holdings (NYSE:ITGR) surges 20% following KKR (NYSE:KKR) report, reducing deal spread

Integer Holdings (NYSE:ITGR) surges 20% following KKR (NYSE:KKR) report, reducing deal spread

NEW YORK, July 31, 2026, 17:05 EDT — U.S. cash markets finished trading

  • Integer ended the session at $121.21, gaining 20.2%, with volume at 6.1 times its 20-session average.
  • A bid of $127 presents a 4.8% gross premium. Initial calculations suggest completion odds of approximately 78%.
  • An expected deal announcement along with August 6 earnings creates an unusually binary week ahead.

Shares of Integer Holdings ended Friday up 20.2% at $121.21, after a report surfaced about a potential KKR acquisition valued around $127. The stock reached a 52-week peak of $123.50.

Stock chart for NYSE:ITGR

The Wall Street Journal referenced a price close to $127, while the Financial Times indicated a broader range of $125 to $130. Integer produces and supplies parts for firms in the medical technology sector.

The rally on Friday boosted Integer’s equity value by around $691 million. However, just $5.79 remains between the closing price and the $127 per share offer, leaving a narrow spread.

A drop back to Thursday’s close of $100.86 would result in a decline of 16.8%. Early projections are based on that closing price as the break value. The calculations also factor in 33.96 million shares and net debt from April.

EV/EBITDA measures overall value relative to a proxy for cash profit. The projections do not account for time value, dilution, or subsequent balance-sheet adjustments.

Reported priceGross upsidePreliminary completion probabilityEquity valueEV/2026 adjusted EBITDA
$1253.1%84%$4.25 billion14.2 times
$1274.8%78%$4.31 billion14.4 times
$1307.3%70%$4.41 billion14.7 times

The likelihood decreases as the proposed offer increases. A higher payout requires less confidence to justify Friday’s price. This represents a risk-arbitrage model rather than a prediction.

Trading volume climbed to 2.61 million shares, exceeding the recent average by 6.1 times. Integer advanced 22.9% over the week, while major indexes saw smaller gains.

AssetFriday closeFriday moveWeekly move
Integer Holdings$121.21rose 20.2%advanced 22.9%
S&P 5007,489.72added 0.70%climbed 1.05%
Nasdaq Composite25,373.85jumped 1.00%increased 1.59%

The announced deal value is higher than consensus analyst estimates. The average of five latest targets stood at $106, with the highest at $115. Friday’s closing price surpassed both figures.

ReferencePriceUpside or downside from Friday
Latest analyst average$106-12.6%
Recent analyst highest$115-5.1%
Recent analyst lowest$96-20.8%
KKR closing price reported$127+4.8%

The basis for comparison changes as a result. On Friday, valuation moved from focusing on earnings targets to centering on reported transaction terms.

Integer launched a strategic review on April 30 following expressions of interest from potential buyers. Chair Pamela G. Bailey said it was “the right time to consider all opportunities.” The board did not provide a timeline or guarantee any deal. Nasdaq

LSEG data shows Irenic Capital Management holds a 3.72% stake. Integer appointed two board members as part of a March deal. The activist had urged the firm to pursue a sale.

The company began the review with lowered outlooks for 2026. Revenue for the first quarter increased by 0.5% to $440 million, while adjusted EBITDA dropped 7% to $85 million.

Adjusted earnings dropped 8% to $1.20 per share. Net debt totaled $1.264 billion. Leverage was 3.2 times adjusted EBITDA.

In April, management reduced all key 2026 midpoints. CEO Payman Khales stated it was “prudent to further risk adjust our outlook.” The following derived changes are initial. GlobeNewswire

2026 metricFebruary midpointApril midpointChange
Sales$1.851 billion$1.820 billion-1.7%
Adjusted operating income$314 million$295 million-6.1%
Adjusted EBITDA$402.5 million$387 million-3.9%
Adjusted EPS$6.54$6.12-6.4%
Operating cash flow$210 million$195 million-7.1%

There are two potential catalysts scheduled for next week. A deal might be announced on Monday or any day later in the week. Integer is set to report its second-quarter earnings on Thursday, August 6, at 9 a.m. EDT.

KKR did not provide a comment to Reuters. Integer was not immediately available for comment. The reports reviewed did not disclose details on financing, terms, or regulatory timeline.

Risks: Negotiations might collapse or the price could be altered. If discussions end unsuccessfully, shares might fall back toward where they traded before reports surfaced. The upcoming Thursday results could also establish a new baseline.

By Friday’s close, Integer appeared less driven by earnings and more by speculation of a takeover, leaving minimal spread.

TS2 TECH • EXTENDED COVERAGE

Further analysis

What caused Integer Holdings shares to surge during the most recent U.S. trading session?
Integer finished at $121.21 on July 31, 2026, gaining 20.18% during the day. KKR was reported to be close to finalizing a take-private agreement at a value between $125 and $130 per share. Trading volume hit 2.61 million shares, which is almost five times the 65-day average. The stock reached a 52-week high of $123.50. The surge was linked to the acquisition news, not a wider movement in the sector. The Wall Street Journal
Has KKR confirmed the takeover is finalized?
No agreement has been confirmed. Integer and KKR have not disclosed a signed deal or definitive price. The reports referenced advanced-stage discussions, cautioning that the deal could still fall through. Integer’s last formal statement was the strategic review revealed on April 30, which weighs options such as a sale, merger, or staying independent. Financial Times
What potential gains are left within the stated offer range?
With shares at $121.21, an offer of $125 suggests a gross upside of approximately 3.1%. At $130, the potential upside is around 7.3%, before accounting for timing and transaction risk. The suggested midpoint of $127.50 translates to about 5.2% upside. Shares were last near $100.86 prior to news of the potential takeover. A movement back to that price would result in an estimated 16.8% downside, not a forecast. The Wall Street Journal
How did ITGR's performance compare with both the overall market and other medical-device shares?
ITGR outperformed the S&P 500 by about 19.5 percentage points. Integer rose 20.18%, while the S&P 500 gained just 0.7%. The Russell 2000 dropped 0.5% on Friday, with the iShares U.S. Medical Devices ETF also down roughly 0.5%. The gap highlights that investors were factoring in takeover chances, rather than improved sector demand. The Wall Street Journal
What do Integer’s most recent operating results indicate?
First-quarter revenue edged up 0.5% year-on-year to $439.6 million. Organic sales recorded a 1.3% increase, but adjusted EPS slid 8.4% to $1.20. Adjusted EBITDA fell 7.0% to $85.1 million for the period. Gross margin narrowed by 260 basis points to 24.9%. Management attributed the margin decline to lower production volumes impacting fixed-cost absorption. These results highlight sluggish growth and compressed margins prior to the sale reports. GlobeNewswire
What are management’s projections for all of 2026?
Management projects a 1% to 3% decrease in sales for 2026, with revenue forecast in the range of $1.805 billion to $1.835 billion. Adjusted EPS outlook is set between $5.83 and $6.40, implying earnings could be flat or decline by up to 9%. The company expects adjusted EBITDA between $375 million and $399 million. Shares at $121.21 are valued at roughly 18.9 to 20.8 times the projected adjusted EPS. The latest takeover report now overshadows this standalone valuation. GlobeNewswire
Does Integer’s level of debt represent a significant risk factor?
On April 3, Integer reported non-GAAP net debt at $1.264 billion. Leverage stood at 3.2 times adjusted EBITDA, up from 3.0 times at the close of the previous year. Cash and equivalents were just $8.1 million. Fixed rates covered 88% of the company’s principal debt. Management projected 2026 operating cash flow in the $185 million to $205 million range. As a result, enterprise value takes precedence over equity value alone. GlobeNewswire
Do Wall Street price targets retain their value after Friday’s rally?
Most listed targets were set before the takeover report and now appear outdated. Truist put its target at $110 on July 16, and KeyBanc at $104 on July 21. Oppenheimer set a $115 target on May 13. On Friday, shares closed at $121.21, surpassing each of these targets. The projections reflected standalone value, not a concluded deal. Forecasts could shift rapidly once terms are finalized or if talks collapse. marketscreener.com
Which upcoming dates and figures should investors monitor?
The first key event is a transaction announcement, which could come as soon as Monday, August 3. Integer is due to report its second-quarter results on Thursday, August 6. Analysts’ consensus points to EPS of $1.38 and revenue at $450.7 million, reflecting about an 11% decline in EPS and a 5% drop in revenue from a year earlier. If no deal is announced, the focus shifts to forecasts and remarks concerning three lagging products. In the meantime, speculation over a potential takeover is likely to drive daily movements in the share price. Financial Times

Leokadia Głogulska is a financial and technology journalist at TS2.tech, covering stocks, artificial intelligence, space technology and global market developments. She graduated from Wrocław University of Economics and Business and previously worked in financial analysis before moving into business journalism. Her reporting focuses on helping readers understand the market trends, companies and technologies shaping the global economy.

AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 STRONG BUY

Xylem

NYSE: XYL 94 / 100
#2 STRONG BUY

AerCap

NYSE: AER 92 / 100
#3 BUY ON WEAKNESS

Visa

NYSE: V 90 / 100
#4 BUY

Chevron

NYSE: CVX 86 / 100
#5 ACCUMULATE

UPS

NYSE: UPS 84 / 100
View full portfolio
Editorial model selection. Not personalised advice.
Bitmine (NYSE:BMNR) drops 6.5% as repurchase activity drives majority of Ether-per-share gains for the week
Previous Story

BitMine Immersion Technologies (NYSE:BMNR) Climbs 9% for the Week Even as Ether Holds Steady

Replimune (NASDAQ:REPL) Shares Soar as FDA Panel Supports RP1 Despite Ongoing Evidence Debate
Next Story

Replimune (NASDAQ:REPL) Shares Soar as FDA Panel Supports RP1 Despite Ongoing Evidence Debate